Not a good buy right now: the primary trend is still bearish (SMA_200 > SMA_20 > SMA_5) and price is trading below the pivot (0.796).
With earnings after hours (2026-02-04), near-term outcome is likely event-driven; estimates/revisions skew negative (no upward EPS revisions; revenue estimates cut), which is a poor setup for an impatient buyer.
Options positioning is aggressively call-skewed (very low put/call ratios) and IV is elevated, suggesting speculative bullishness—but that can reverse sharply around earnings.
Momentum: MACD histogram slightly positive (0.00144) but “positively contracting,” implying upside momentum is fading.
RSI: RSI_6 ~22.99 (oversold/very weak momentum). This can fuel short bounces, but by itself doesn’t confirm a reversal.
Pattern-based bias: Similar-pattern stats imply modest positive drift (next day +0.29%, next week +1.22%, next month +6.7%), but this is secondary to the downtrend + earnings catalyst today.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning/sentiment: Extremely call-heavy open interest (P/C OI 0.05) and call-heavy volume (P/C vol 0.19) = bullish/speculative sentiment.
Activity: Today’s option volume elevated vs 30D average (~133.9%), showing heightened event interest.
Volatility: 30D IV ~96.77 vs HV ~77.15 (IV > HV) = expensive implied move pricing into/around earnings.
Skew/interpretation: Call crowding can support a pop if results surprise positively, but also raises risk of a sharp drop if earnings disappoint and IV crush hits option holders.
Technical Summary
Sell
9
Buy
4
Positive Catalysts
near S1 support (0.
can enable a quick technical bounce if earnings/guide is merely “less bad.”
Neutral/Negative Catalysts
toward 0.
No supportive flow signals: hedge fund and insider activity listed as Neutral; no congress activity to indicate influential accumulation.
Financial Performance
Latest reported quarter: 2026/Q1.
Revenue: $93.94M, down ~7.49% YoY (top-line contraction).
Profitability: Net income -$21.68M (still a sizable loss); EPS -0.18.
Margins: Gross margin 28.34%, down ~15.93% YoY (deteriorating efficiency/price/mix).
Overall: Growth and margins are trending the wrong direction heading into the next earnings print.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No explicit Wall Street rating/price target dataset was provided here.
What we do have (proxy for Street stance): estimate/revision tone is negative—no upward EPS revisions and revenue estimates have been revised downward twice in the last three months.
Pros view (implied): potential for earnings-driven upside if they beat revenue again (historical revenue beat rate noted).
Cons view (implied): declining revenue expectations + compressed gross margin + continuing losses keep the fundamental case weak, aligning with the current bearish technical setup.
Wall Street analysts forecast ARAY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ARAY is 4 USD with a low forecast of 4 USD and a high forecast of 4 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast ARAY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ARAY is 4 USD with a low forecast of 4 USD and a high forecast of 4 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.600
Low
4
Averages
4
High
4
Current: 0.600
Low
4
Averages
4
High
4
BTIG
Buy
downgrade
$4 -> $2
AI Analysis
2026-02-05
New
Reason
BTIG
Price Target
$4 -> $2
AI Analysis
2026-02-05
New
downgrade
Buy
Reason
BTIG lowered the firm's price target on Accuray to $2 from $4 and keeps a Buy rating on the shares. The firm cites the company's sales and EBITDA cut on geopolitical pressures, the analyst tells investors in a research note.
BTIG
Buy
maintain
$4 -> $5
2025-08-14
Reason
BTIG
Price Target
$4 -> $5
2025-08-14
maintain
Buy
Reason
BTIG raised the firm's price target on Accuray to $5 from $4 and keeps a Buy rating on the shares. The company's Q4 sales beat was driven by $70.7M in Product revenue and the firm applauds Accuray's ability to execute through a hectic final quarter in FY25, as shipments to China were essentially halted at the start of the quarter and then resumed in May with tariff rates easing, the analyst tells investors in a research note.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ARAY
